Home›Stock Screener›Natraj Proteins›Financial Statements

Natraj Proteins Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Natraj Proteins (NATRAJPR) reported revenue ₹101 Cr, net profit ₹1 Cr and EPS ₹3.03, with a net profit margin of 1.0% and ROE of 3.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review Natraj Proteins P/E valuation to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 0.99% 2026 data
EBITDA Margin 3.96% 2026 data
Operating Margin 4.00% 2026 data
Return on Assets 1.32% 2026 data
Return on Equity 3.03% 2026 data

Balance Sheet Ratios

Current Ratio 61.00 2026 data
Equity Ratio 43.42% 2026 data
Asset Turnover 1.33 2026 data

NATRAJPR Revenue, Net Profit & EBITDA — Year-on-Year Growth

NATRAJPR YoY (March 2025 vs March 2026) — revenue -14.4%, net profit +150.0%, EBITDA +100.0%, expenses -16.2%. For live price, earnings ratios and company overview, see NATRAJPR share price.

Revenue Growth
-14.4%
Year-over-Year
Net Profit Growth
+150.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
-16.2%
Year-over-Year
Assets Growth
+28.8%
Year-over-Year
Equity Growth
+3.1%
Year-over-Year
Operating Cash Flow Growth
+466.7%
Year-over-Year
Investing Cash Flow Growth
-400.0%
Year-over-Year
Financing Cash Flow Growth
-766.7%
Year-over-Year

NATRAJPR Income Statement — Revenue, EBITDA & Net Profit

Natraj Proteins revenue ₹101 Cr, EBITDA ₹4 Cr, net profit ₹1 Cr, EPS ₹3.03 (2026) — net profit margin 1.0%. Explore NATRAJPR value investing to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 101 118 194 144 145 146 154 191 196 259 202 302
Expenses 98 117 203 141 131 143 150 185 189 255 203 296
EBITDA 4 2 -9 3 14 3 5 6 7 5 -1 7
Operating Profit Margin % 4.00% 1.00% -5.00% 2.00% 10.00% 2.00% 3.00% 3.00% 3.00% 2.00% -1.00% 2.00%
Depreciation 0 0 0 0 0 0 1 1 1 1 1 1
Interest 2 2 3 2 1 2 4 4 4 4 3 5
Profit Before Tax 1 -1 -13 1 13 1 0 1 2 0 -5 2
Tax 0 0 0 0 4 1 0 0 0 0 0 0
Net Profit 1 -2 -13 1 9 0 0 1 2 0 -5 2
Earnings Per Share (₹) 3.03 -3.90 -33.41 1.90 24.99 1.05 0.90 3.06 4.29 0.60 -14.18 4.05

NATRAJPR Balance Sheet — Assets, Liabilities & Shareholders' Equity

NATRAJPR total assets ₹76 Cr, total equity ₹33 Cr, total liabilities ₹ Cr (2026) — ROE 3.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 76 59 78 89 76 69 71 72 106 65 71 96
Current Assets 61 43 63 75 64 61 65 66 98 54 61 81
Fixed Assets 6 5 6 4 4 3 3 4 4 4 5 6
Capital Work in Progress 0 1 0 2 0 0 0 0 0 0 0 2
Investments 52 0 1 0 1 0 0 0 0 0 0 0
Other Assets 0 52 72 83 71 66 68 69 102 61 66 87
LIABILITIES
Total Liabilities
Current Liabilities 1 2 2 3 4 1 1 1 1 1 1 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 33 32 34 46 46 36 36 35 34 33 33 38
Share Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 30 29 30 43 42 32 32 32 31 29 29 34

NATRAJPR Cash Flow Statement — Operating, Investing & Financing

Natraj Proteins operating cash flow ₹22 Cr, investing ₹-3 Cr, financing ₹-20 Cr, net cash flow ₹-1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 22 -6 3 6 9 2 30 -38 3 9 25
Investing Activities -3 1 -3 -3 0 0 2 3 -2 4 -2
Financing Activities -20 3 -2 2 -11 -4 -28 31 -4 -27 -13
Net Cash Flow -1 -2 -2 5 -2 -2 4 -3 -3 -14 10